Drug research: myths, hype and reality
The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
Molecular properties that influence the oral bioavailability of drug candidates
Veber, D. F., Johnson, S. R., Cheng, H.-Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020017n · Cited by 8,420
Drug-like properties and the causes of poor solubility and poor permeability
Lipinski, C. A. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00107-6 · Cited by 3,734
Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305
Ertl, P., Rohde, B., & Selzer, P. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000942e · Cited by 3,084
ADMET in silico modelling: towards prediction paradise?
van de Waterbeemd, H., & Gifford, E. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1032 · Cited by 1,863
Molecular Complexity and Its Impact on the Probability of Finding Leads for Drug Discovery
Hann, M. M., Leach, A. R., & Harper, G. (2001) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci000403i · Cited by 877
The Design of Leadlike Combinatorial Libraries
Teague, S. J., Davis, A. M., Leeson, P. D., & Oprea, T. (1999) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19991216)38:24<3743::aid-anie3743>3.0.co;2-u · Cited by 870
Kelder, J., Grootenhuis, P. D. J., Bayada, D. M., Delbressine, L. P. C., & Ploemen, J.-P. (1999) · Pharmaceutical Research · doi:10.1023/a:1015040217741 · Cited by 813
Research works printed but not linked: 1
- Watson, J. D., with Berry, A. DNA. The Secret of Life. (William Heinemann, London, 2003).
Cited by
Items 101–200 of 353
Abou-Gharbia, M. A., & Childers, W. E. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401564r · Cited by 58
Advances in nuclear magnetic resonance for drug discovery
Powers, R. (2009) · Expert Opinion on Drug Discovery · doi:10.1517/17460440903232623 · Cited by 53
Soliman, M. E. S., Adewumi, A. T., Akawa, O. B., Subair, T. I., Okunlola, F. O., Akinsuku, O. E., & Khan, S. (2022) · AAPS PharmSciTech · doi:10.1208/s12249-022-02229-5 · Cited by 53
Capter 11 Filtering in Drug Discovery
Lipinski, C. A. (2005) · Annual reports in computational chemistry · doi:10.1016/s1574-1400(05)01011-x · Cited by 53
Montès, M., Miteva, M. A., & Villoutreix, B. O. (2007) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.21405 · Cited by 50
Thiele, J., Windbergs, M., Abate, A. R., Trebbin, M., Shum, H. C., Förster, S., & Weitz, D. A. (2011) · Lab on a Chip · doi:10.1039/c1lc20298g · Cited by 53
Case histories, magic bullets and the state of drug discovery
Drews, J. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2084 · Cited by 57
Vangala, S., & Tonelli, A. P. (2007) · The AAPS Journal · doi:10.1208/aapsj0903031 · Cited by 50
Differences between High- and Low-Affinity Complexes of Enzymes and Nonenzymes
Carlson, H. A., Smith, R. D., Khazanov, N. A., Kirchhoff, P. D., Dunbar, J. B., & Benson, M. L. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8006504 · Cited by 46
Molecular Property Filters Describing Pharmacokinetics and Drug Binding
García‐Sosa, A. T., Maran, U., & Hetényi, C. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712799945021 · Cited by 48
Fromin vivotoin vitro/in silicoADME: progress and challenges
Waterbeemd, H. V. D. (2005) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.1.1.1 · Cited by 47
Defining the Role of Pharmacology in the Emerging World of Translational Research
Enna, S. J., & Williams, M. J. (2009) · Advances in pharmacology · doi:10.1016/s1054-3589(08)57001-3 · Cited by 49
In silico models for genotoxicity and drug regulation
Benigni, R., Bassan, A., & Pavan, M. (2020) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2020.1785428 · Cited by 43
Diced Electrophoresis Gel Assay for Screening Enzymes with Specified Activities
Komatsu, T., Hanaoka, K., Adibekian, A., Yoshioka, K., Terai, T., Ueno, T., Kawaguchi, M., Cravatt, B. F., & Nagano, T. (2013) · Journal of the American Chemical Society · doi:10.1021/ja401792d · Cited by 42
Druggability predictions: methods, limitations, and applications
Barril, X. (2012) · Wiley Interdisciplinary Reviews Computational Molecular Science · doi:10.1002/wcms.1134 · Cited by 46
Steindl, T. M., Crump, C. E., Hayden, F. G., & Langer, T. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050343d · Cited by 43
Luthra, T., Banothu, V., Adepally, U., Kumar, K. G., Swathi, M., Chakrabarti, S., Maddi, S. R., & Sen, S. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112034 · Cited by 40
Koppitz, M., & Eis, K. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.04.005 · Cited by 40
Evidence of Weak Halogen Bonding: New Insights on Itraconazole and its Succinic Acid Cocrystal
Nonappa, N., Lahtinen, M., Kolehmainen, E. T., Haarala, J., & Shevchenko, A. (2012) · Crystal Growth & Design · doi:10.1021/cg3015282 · Cited by 42
On the Hyping of Scholarly Research (with a Shout-Out to ChatGPT)
Jandrić, P. (2024) · Postdigital Science and Education · doi:10.1007/s42438-023-00402-y · Cited by 38
Stegemann, S. (2015) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2015.11.003 · Cited by 49
Chemical Space Expansion of Bromodomain Ligands Guided by in Silico Virtual Couplings (AutoCouple)
Batiste, L., Unzue, A., Dolbois, A., Hassler, F., Wang, X., Deerain, N., Zhu, J., Spiliotopoulos, D., Nevado, C., & Caflisch, A. (2018) · ACS Central Science · doi:10.1021/acscentsci.7b00401 · Cited by 43
Novel Statistical Approach for Primary High-Throughput Screening Hit Selection
Yan, S. F., Asatryan, H., Li, J., & Zhou, Y. (2005) · Journal of Chemical Information and Modeling · doi:10.1021/ci0502808 · Cited by 40
NMR Metabolic Profiling of Aspergillus nidulans to Monitor Drug and Protein Activity
Forgue, P., Halouska, S., Werth, M. T., Xu, K., Harris, S., & Powers, R. (2006) · Journal of Proteome Research · doi:10.1021/pr060114v · Cited by 37
Saba, A., Sarwar, F., Muhammad, S., Ilyas, M., Javed Iqbal, M., Al-Sehemi, A. G., Ayub, K., Gilani, M. A., & Adnan, M. (2022) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2022.120234 · Cited by 36
The fall and rise of pharmacology – (Re-)defining the discipline?
Winquist, R. J., Mullane, K., & Williams, M. J. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.09.011 · Cited by 44
Simulation models for drug disposition and drug interactions
Dickins, M., & Waterbeemd, H. V. D. (2004) · Drug Discovery Today BIOSILICO · doi:10.1016/s1741-8364(04)02388-1 · Cited by 42
Translational paradigms in pharmacology and drug discovery
Mullane, K., Winquist, R. J., & Williams, M. J. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.10.019 · Cited by 35
Discriminative frequent subgraph mining with optimality guarantees
Thoma, M., Cheng, H., Gretton, A., Han, J., Kriegel, H., Smola, A. J., Song, L., Yu, P. S., Yan, X., & Borgwardt, K. M. (2010) · Statistical Analysis and Data Mining The ASA Data Science Journal · doi:10.1002/sam.10084 · Cited by 34
Vučićević, J., Nikolic, K. M., & Mitchell, J. B. O. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867324666170712115411 · Cited by 37
Flagging Drugs That Inhibit the Bile Salt Export Pump
Montanari, F., Pinto, M., Khunweeraphong, N., Wlcek, K., Sohail, M. I., Noeske, T., Boyer, S. K., Chiba, P., Stieger, B., Kuchler, K., et al. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00594 · Cited by 37
Predicting the carcinogenicity of chemicals with alternative approaches: recent advances
Benigni, R. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.934670 · Cited by 31
Application of data mining approaches to drug delivery
Ekins, S., Shimada, J., & Chang, C. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.005 · Cited by 35
New Tools and New Biology: Recent Miniaturized Systems for Molecular and Cellular Biology
Hamon, M., & Hong, J. W. (2013) · Molecules and Cells · doi:10.1007/s10059-013-0333-1 · Cited by 31
Chen, T., Benmohamed, R., Arvanites, A. C., Ranaivo, H. R., Morimoto, R. I., Ferrante, R. J., Watterson, D. M., Kirsch, D. R., & Silverman, R. B. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.10.052 · Cited by 31
Williams, M. J. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.08.019 · Cited by 34
Translational semantics and infrastructure: another search for the emperor's new clothes?
Mullane, K., & Williams, M. J. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.01.004 · Cited by 30
Predicting Oral Druglikeness by Iterative Stochastic Elimination
Rayan, A., Marcus, D., & Goldblum, A. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci9004354 · Cited by 29
Target (In)Validation: A Critical, Sometimes Unheralded, Role of Modern Medicinal Chemistry
Sweis, R. F. (2015) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5b00183 · Cited by 29
Advancements and Potential Applications of Microfluidic Approaches—A Review
Ahmed, I., Akram, Z., Bule, M. H., & Iqbal, H. M. N. (2018) · Chemosensors · doi:10.3390/chemosensors6040046 · Cited by 30
Zhao, S., Liu, L., Fu, Y., & Guo, Q. (2004) · Journal of Physical Organic Chemistry · doi:10.1002/poc.856 · Cited by 30
Johnston, K. L., Cook, D. A. N., Berry, N. G., Hong, W. D., Clare, R. H., Goddard, M., Ford, L., Nixon, G. L., O’Neill, P. M., Ward, S. A., et al. (2017) · Science Advances · doi:10.1126/sciadv.aao1551 · Cited by 33
Determining the optimal size of small molecule mixtures for high throughput NMR screening
Mercier, K., & Powers, R. (2005) · Journal of Biomolecular NMR · doi:10.1007/s10858-005-0948-4 · Cited by 28
Agrafiotis, D. K., Wiener, J. J. M., Skalkin, A., & Kolpak, J. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci200054u · Cited by 27
In silico antitarget screening
Recanatini, M., Bottegoni, G., & Cavalli, A. (2004) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2004.10.004 · Cited by 32
Santos, L. H., Ferreira, R. S., & Caffarena, E. R. (2015) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-02760150239 · Cited by 32
Is there a case for selectively promiscuous anticancer drugs?
Fernández, A., Crespo, A., & Tiwari, A. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.10.008 · Cited by 26
Understanding human rhinovirus infections in terms of QSAR
Verma, R. P., & Hansch, C. H. (2006) · Virology · doi:10.1016/j.virol.2006.09.012 · Cited by 26
Classification Models for Safe Drug Molecules
Мадан, А. К., Bajaj, S., & Dureja, H. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-059-5_5 · Cited by 25
Diced electrophoresis gel assay for screening enzymes with specified activities
Komatsu, T. (2015) · SEIBUTSU BUTSURI KAGAKU · doi:10.2198/electroph.59.115 · Cited by 24
Lead discovery and in silico 3D structure modeling of tumorigenic FAM72A (p17)
Pramanik, S., Kutzner, A., & Heese, K. (2014) · Tumor Biology · doi:10.1007/s13277-014-2620-7 · Cited by 26
Integration of Small‐Molecule Discovery in Academic Biomedical Research
Ohlmeyer, M. H. J., & Zhou, M. (2010) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20197 · Cited by 24
In Silico ADME/Tox Predictions
Lagorce, D., Reynès, C., Camproux, A., Miteva, M. A., Spérandio, O., & Villoutreix, B. O. (2010) · Wiley eBooks · doi:10.1002/9780470915110.ch2 · Cited by 29
Blocking the Hype‐Hypocrisy‐Falsification‐Fakery Pathway is Needed to Safeguard Science
Hopf, H., Matlin, S. A., Mehta, G., & Krief, A. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201911889 · Cited by 23
Screening Pipeline for Flavivirus Based Inhibitors for Zika Virus NS1
Raza, S., Abbas, G., & Azam, S. S. (2019) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2019.2911081 · Cited by 23
Gadaleta, D., Serrano‐Candelas, E., Ortega-Vallbona, R., Colombo, E., de Lomana, M. G., Biava, G., Aparicio-Sánchez, P., Roncaglioni, A., Gozalbes, R., & Benfenati, E. (2024) · Journal of Cheminformatics · doi:10.1186/s13321-024-00931-z · Cited by 30
To Be Drug or Prodrug: Structure-Property Exploratory Approach Regarding Oral Bioavailability
Damião, M. C. F. C. B., Pasqualoto, K. F. M., Polli, M. C., & Parise‐Filho, R. (2014) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3bs4h · Cited by 22
Cabrera‐Pérez, M. Á., Sanz, M. B., Sanjuan, V. M., González‐Álvarez, M., & González‐Álvarez, I. (2015) · Elsevier eBooks · doi:10.1016/b978-0-08-100094-6.00002-x · Cited by 24
Optimization of piperazine-derived ureas privileged structures for effective antiadenovirus agents
Mazzotta, S., Marrugal‐Lorenzo, J. A., Vega‐Holm, M., Serna‐Gallego, A., Álvarez-Vidal, J., Berastegui‐Cabrera, J., del Palacio, J. P., Díaz, C., Aiello, F., Pachón, J., et al. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111840 · Cited by 22
Polański, J. (2009) · Elsevier eBooks · doi:10.1016/b978-044452701-1.00006-5 · Cited by 22
Mining Statistically Significant Molecular Substructures for Efficient Molecular Classification
Ranu, S., & Singh, A. K. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci900035z · Cited by 21
Hawas, S. S., El‐Sayed, S. M., Elzahhar, P. A., & Moustafa, M. A. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2023.106874 · Cited by 20
Overview of Drug Discovery and Development
Ator, M. A., Mallamo, J. P., & Williams, M. J. (2006) · Current Protocols in Pharmacology · doi:10.1002/0471141755.ph0909s35 · Cited by 23
Smyth, L. A., Matthews, T. P., & Collins, I. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.03.069 · Cited by 19
One Size Does Not Fit All: Challenging Some Dogmas and Taboos in Drug Discovery
Chai, C. L. L., & Mátyus, P. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.167 · Cited by 22
Medicinal chemistry education: what is needed and where is it going?
Krogsgaard‐Larsen, P., Pelliciari, R., Souza, N. D., Timmerman, H., Triggle, D. J., van Boeckel, C. A. A., & Wasley, J. W. F. (2005) · Drug Development Research · doi:10.1002/ddr.20038 · Cited by 19
Choudhury, C., Priyakumar, U. D., & Sastry, G. N. (2016) · Journal of Chemical Sciences · doi:10.1007/s12039-016-1069-1 · Cited by 18
A High-Throughput 1,536-Well Luminescence Assay for Glutathione S-Transferase Activity
Yasgar, A., Shultz, J. W., Zhou, W., Wang, H., Huang, F., Murphy, N., Abel, E. L., DiGiovanni, J., Inglese, J., & Simeonov, A. M. (2010) · Assay and Drug Development Technologies · doi:10.1089/adt.2009.0248 · Cited by 19
Ganguly, M., Brown, N., Schuffenhauer, A., Ertl, P., Gillet, V. J., & Greenidge, P. A. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci050529l · Cited by 18
Amir-Aslani, A. (2007) · Technological Forecasting and Social Change · doi:10.1016/j.techfore.2007.10.002 · Cited by 18
Overview: Differentiating Issues in the Development of Macromolecules Compared with Small Molecules
Blaich, G., Janssen, B., Roth, G. P., & Salfeld, J. G. (2010) · Wiley eBooks · doi:10.1002/9780470571224.pse292 · Cited by 20
De-Risking Drug Discovery with ADDME — A voiding D rug D evelopment M istakes E arly
Tsaioun, K., & Jacewicz, M. S. (2009) · Alternatives to Laboratory Animals · doi:10.1177/026119290903701s10 · Cited by 19
Recent Advances in the Design of Self‐Delivery Amphiphilic Drugs and Vaccines
Xi, J., & Liu, H. (2019) · Advanced Therapeutics · doi:10.1002/adtp.201900107 · Cited by 16
A combined tissue‐engineered/in silico signature tool patient stratification in lung cancer
Göttlich, C., Kunz, M., Zapp, C., Nietzer, S., Walles, H., Dandekar, T., & Dandekar, G. (2018) · Molecular Oncology · doi:10.1002/1878-0261.12323 · Cited by 16
Evans, L., Hedger, J. N., O’Donnell, G., Skelton, B. W., WHITE, A. H., Williamson, R. T., & Gibbons, S. (2010) · Tetrahedron Letters · doi:10.1016/j.tetlet.2010.08.036 · Cited by 16
Mohan, A., Kirubakaran, R., Parray, J. A., Sivakumar, R., Murugesh, E., & Govarthanan, M. (2019) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2019.127670 · Cited by 16
Valencia, Z. S., Kingston, J. L. T., Miljković, F. N., Rowbottom, H., Mann, N., Davies, S., Ekblad, M., Castro, S. D., Kwapień, K., Malmerberg, E., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c01642 · Cited by 17
The multiple meanings of translational research in (bio)medical research
Krueger, A. K., Hendriks, B., & Gauch, S. (2019) · History & Philosophy of the Life Sciences · doi:10.1007/s40656-019-0293-7 · Cited by 24
Analysing microarray data in drug discovery using systems biology
Chen, B., & Li, C. (2007) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2.5.755 · Cited by 16
Eldebss, T. M. A., Farag, A. M., Abdalla, M. M., & Khedr, A. A. (2019) · Journal of Heterocyclic Chemistry · doi:10.1002/jhet.3433 · Cited by 15
Sengupta, P., Puri, C. S., Chokshi, H. A., Sheth, C. K., Midha, A. S., Chitturi, T. R., Thennati, R., Murumkar, P. R., & Yadav, M. R. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.09.018 · Cited by 15
Middleton, D. A. (2006) · Annual reports on NMR spectroscopy · doi:10.1016/s0066-4103(06)60002-1 · Cited by 15
Ahmed, S. S. S. J., Ahameethunisa, A. R., & Santosh, W. (2010) · Journal of Theoretical and Computational Chemistry · doi:10.1142/s0219633610006146 · Cited by 14
The Concept of Ideal Drug &its Realization Opportunity using Nanopharmaceutical Research Scenario
Aithal, A., & Aithal, P. S. (2018) · International Journal of Health Sciences and Pharmacy · doi:10.47992/ijhsp.2581.6411.0031 · Cited by 15
Unraveling Caco-2 cells through functional and transcriptomic assessments
Jeong, Y., Shea, K. I., & Ford, K. A. (2025) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2025.105771 · Cited by 14
Successful pharmaceutical discovery: Paul Janssen's concept of drug research
Lewi, P. J., & Smith, A. (2007) · R and D Management · doi:10.1111/j.1467-9310.2007.00481.x · Cited by 15
Lu, G., Tandang‐Silvas, M. R., Dawson, A., Dawson, T. J., & Groppe, J. C. (2018) · Bone · doi:10.1016/j.bone.2018.03.027 · Cited by 15
Predicting Selectivity and Druggability in Drug Discovery
Cheng, A. C. (2008) · Annual reports in computational chemistry · doi:10.1016/s1574-1400(08)00002-9 · Cited by 13
Computational prediction of drug toxicity: the case of mutagenicity and carcinogenicity
Benigni, R. (2004) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2004.09.003 · Cited by 13
Systems Biology and Cancer Prevention: All Options on the Table
Rosenfeld, S., & Kapetanović, I. M. (2008) · Gene Regulation and Systems Biology · doi:10.4137/grsb.s1114 · Cited by 13
Phospho-specific flow cytometry in drug discovery
Clutter, M. R., Krutzik, P. O., & Nolan, G. P. (2005) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2005.08.010 · Cited by 13
Tong, S., Sun, C., Cao, X., Zheng, Q., Zhang, H., Firempong, C. K., Feng, Y., Yang, Y., Yu, J., & Xu, X. (2014) · Biomedical Chromatography · doi:10.1002/bmc.3189 · Cited by 12
Benson, N. (2015) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2015.07.003 · Cited by 12
Young, L., Geldenhuys, W. J., Domingo, O. C., Malan, S. F., & der Schyf, C. J. V. (2016) · Archiv der Pharmazie · doi:10.1002/ardp.201500293 · Cited by 12
Why optimize cancer drugs for ADMET?
Sheppard, G. S., & Bouska, J. J. (2005) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2005.10.001 · Cited by 12
Solubility, Solubilization and Dissolution in Drug Delivery During Lead Optimization
Hageman, M. J. (2007) · Springer eBooks · doi:10.1007/978-0-387-44961-6_5 · Cited by 12
Shen, C., Dillissen, E., Kasran, A., Lin, Y., Clydesdale, G. J., Sienaert, I., Jonghe, S. D., Gao, L., Geboes, K. J., Boon, L., et al. (2006) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2006.26.575 · Cited by 12
Hop, C. E. C. A. (2012) · Wiley eBooks · doi:10.1002/9780470921920.edm049 · Cited by 15
Performance of Protein–Ligand Docking with Simulated Chemical Shift Perturbations
ten Brink, T., Aguirre, C., Exner, T. E., & Krimm, I. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci500446s · Cited by 11
Drug Targets, Target Identification, Validation, and Screening
den Broeck, W. M. M. V. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-417205-0.00003-1 · Cited by 12
Metadata
- Authors
- Kubinyi, H.
- Corresponding author
- Kubinyi, Hugo
- Venue
- Nature Reviews Drug Discovery
- Published
- 2003-08
- Volume
- 2
- Issue
- 8
- Pages
- 665-668
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1487233798
- Cited by
- 348
- References
- 32
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 13 · 2023: 6 · 2022: 9 · 2021: 4 · 2020: 9 · 2019: 16 · 2018: 24 · 2017: 8 · 2016: 15 · 2015: 17 · 2014: 16 · 2013: 17 · 2012: 26
- FWCI
- 1.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
- Physical Sciences › Chemistry › Organic Chemistry › Synthesis and Characterization of Heterocyclic Compounds
- Keywords
- drug discovery, lead-like compounds, drug-like molecules, oral bioavailability, combinatorial chemistry, high-throughput screening, ADME, computer-aided drug design, structure-based drug design, lead optimization, medicinal chemistry
- MeSH terms
- Chemistry, Pharmaceutical, Humans, Pharmacokinetics, Pharmacology, Research, Technology, Pharmaceutical
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.